We speak to the next person in our 14 most influential people in pharmacy campaign, as voted by you
Community pharmacist/managing partner, Capital Chemist Coburg North
Project pharmacist, PSA
President, Chronic Pain Australia
Board member, Harm Reduction Victoria
Board member, Hepatitis Victoria
Jarrod McMaugh has in-depth experience of community pharmacy as well as the broader health sector.
The Victorian pharmacist wears many hats across a variety of organisations including Hepatitis Victoria, Harm Reduction Victoria, Chronic Pain Australia and the PSA.
He was also recently involved with the Pharmacy Board’s discussions around pharmacist prescribing and the implementation of voluntary assisted dying in his state.
Mr McMaugh is particularly passionate about seeing greater collaboration between pharmacists across settings, and between pharmacists and other health professions.
“I’m always looking at the location of where pharmacists practise and getting us beyond the idea of it being one site of practice for your entire career,” he tells AJP.
“Pharmacists should be able to transition between community and hospital and nursing home and general practice.
“An example of [collaboration] would be the role of pharmacists in GP clinics and in nursing homes. This would give us a lot more capacity to have interprofessional collaboration,” he explains.
“So a community pharmacist will be able to the contact [a pharmacist] working in a nursing home, for instance, and discuss a resident’s treatment in a way that is very contextualised and easier to achieve, because a pharmacist working in a nursing home will have an understanding of what a pharmacist’s role and expertise is.
“You eliminate some of those barriers to communication that can exist between settings.”
There should also be greater access to funding [for pharmacists] for the same work that other people do.
Mr McMaugh wants to see broadened scope of practice for pharmacists in Australia, as well as more funding to support these roles.
“We have a scope of practice that we can see with international practice. We can see pharmacists in other jurisdictions who have the same training as us who are able to utilise that training and expertise in a way that we don’t have access to in Australia,” he says.
“That is both through recognition of what those roles are, and funding for those roles.
“I want to see more activity that we’ve already started, for example, immunisations. Pharmacists have the same training and expertise as any other health professional in the provision of immunisations.
“Once they have that accreditation, [provision] should be persistent and consistent. Wherever you practice, you should be able to provide that service.
“There should also be greater access to funding for the same work that other people do, so if you’ve got a health practitioner who is qualified and recognised by their professional board to provide a particular service, and one is funded to do that via Medicare and another is not, that’s not very efficient use of health resources,” says Mr McMaugh.
“So pharmacists who are accredited and approved to provide a service that is funded for another health professional should get the same funding. Short answer there is – access to Medicare provider numbers and funding. Accessing the existing funding that exists shouldn’t be restricted, it should be broader.”
See the full list of the 14 most influential people in pharmacy here